title: Combination therapy with FK 506 and splenectomy may induce tolerance in cardiac xenografts.
authors.affiliation: Department of Surgical Research, National Cardiovascular Center Suita, Osaka, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Nishimori
authors.forename: S
authors.initials: S
authors.lastname: Suzuki
authors.forename: K
authors.initials: K
authors.lastname: Kido
authors.forename: H
authors.initials: H
authors.lastname: Tashiro
authors.forename: S
authors.initials: S
authors.lastname: Arita
authors.forename: H
authors.initials: H
authors.lastname: Ohdan
authors.forename: H
authors.initials: H
authors.lastname: Amemiya
mesh_terms: D000818:Animals; D003131:Combined Modality Therapy; D006224:Cricetinae; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology; D016027:Heart Transplantation / Q000276:immunology*; D007108:Immune Tolerance; D016131:Lymphocyte Subsets / Q000276:immunology; D008297:Male; D008647:Mesocricetus; D051381:Rats; D011912:Rats, Inbred ACI; D013156:Splenectomy; D016559:Tacrolimus / Q000097:blood / Q000627:therapeutic use*; D013997:Time Factors; D014183:Transplantation, Heterologous / Q000276:immunology*
chemical_list: D016559:Tacrolimus